Respiratory

Latest News

biosimilars check-in banner
Biosimilars Check-In: BI Launches Unbranded Adalimumab; New Omalizumab Deal; CRL for Insulin Aspart

October 10th 2023

Boehringer Ingelheim (BI) launches an unbranded version of its adalimumab biosimilar; Alvotech and Kashiv Biosciences partner for an omalizumab biosimilar candidate; the FDA issues a complete response letter (CRL) for Biocon’s insulin aspart biosimilar.

eye on pharma banner
Eye on Pharma: Omalizumab Results; Korean Insulin Launch; Quebec to Cover Byooviz

July 12th 2023

doctor holding computerized image of lungs
Celltrion Confirms Biosimilarity of Xolair Biosimilar

April 10th 2023

doctor holding computerized pair of lungs
Preclinical Study Shows Comparability Between Omalizumab Biosimilar, Xolair

February 11th 2023

red liquid in a test tube surrounded by other test tubes containing clear liquid
Celltrion Biosimilar Demonstrates Equivalence With Xolair in Phase 1 Study

March 14th 2022

More News

© 2024 MJH Life Sciences

All rights reserved.